Strides Pharma Science reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr

Strides Pharma Science has reported total income of Rs. 1,229.52 crores during the period ended September 30, 2024

Indoco Remedies posts Q2 FY25 consolidated loss at Rs. 9.57 Cr

Indoco Remedies has reported total income of Rs. 434.22 crores during the period ended September 30, 2024

Laurus Labs posts Q2 FY25 consolidated PAT at Rs. 19.84 Cr

Laurus Labs has reported total income of Rs. 1,228.30 crores during the period ended September 30, 2024

AIIMS Delhi hosts workshop on ‘Emerging Technologies for Healthcare’

The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power

Aarti Drugs posts Q2 FY25 consolidated profit at Rs. 35.01 Cr

Aarti Drugs has reported total income of Rs. 599.81 crores during the period ended September 30, 2024

Mankind Pharma completes acquisition of BSV

Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.

Thyrocare Technologies posts Q2 FY25 consolidated net profit at of Rs. 26.67 Cr

Thyrocare Technologies has reported total income of Rs. 179.97 crores during the period ended September 30, 2024

Jagsonpal Pharmaceuticals Q2 FY25 net profit up at Rs. 11.45 Cr

Jagsonpal Pharmaceuticals has reported total income of Rs. 76.34 crores during the period ended September 30, 2024

Syngene International posts Q2 FY25 consolidated PAT at Rs. 106.1 Cr

Piramal Pharma reports Q2 FY25 consolidated PAT at Rs. 22.59 Cr

Piramal Pharma has reported total income of Rs. 2,302.86 crores during the period ended September 30, 2024